IPO Issue Details
Issue Price / Price Band₹114 per share (Fixed Price)
Face Value₹2 Per Share
Lot Size128 Shares per Lot
Total Issue Size2,20,00,000 shares (aggregating up to ₹[.] Cr
Issue TypeBook Built Issue
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenNot Available
Subscription CloseNot Available
Basis of Allotment~6 days after close
Initiation of Refunds~7 days after close
Credit of Shares to Demat~7 days after close
Listing DateTue, 30 Dec 2025
UPI Mandate Deadline2025-12-24
Application & Investment Details
Retail — Min (1 Lots)₹14,592 — 128 shares
Retail — Max (13 Lots)₹189,696 (13 Lots)
HNI — Min (69 Lots)₹10,06,848 — 8,832 shares
QIB Quota75.00% of Issue
NII / HNI Quota15.00% of Issue
Retail Quota10.00% of Issue
EPS (Pre-IPO)₹1.85
EPS (Post-IPO)₹2.74
P/E Ratio (Pre-IPO)61.62x
P/E Ratio (Post-IPO)41.59x
Pre-IPO Promoter Holding5,68,43,250 shares
Post-IPO Promoter Holding7,88,43,250 shares
About Gujarat Kidney & Super Speciality Ltd.
Gujarat Kidney & Super Speciality Ltd. is proposing an Initial Public Offering (IPO) on the NSE SME platform under the SME category.
The total issue size is 2,20,00,000 shares (aggregating up to ₹[.] Cr.
The IPO subscription opens on the announced date and closes on the announced date. Listing is expected on 30 Dec 2025.
Investors can apply through ASBA or UPI via their broker app.
Shareholding & Lock-in
Pre-IPO Promoter Holding
5,68,43,250 shares
Post-IPO Promoter Holding
7,88,43,250 shares
IPO Subscription Status
Listed on 30 Dec 2025
Final subscription figures recorded below
UPI Mandate Deadline: 2025-12-24
Important Dates
Subscription OpensTo be announced
Subscription ClosesTo be announced
Basis of Allotment~6 days after close
Listing DateTue, 30 Dec 2025
UPI Mandate Deadline2025-12-24
Lot Size & Investment Table
| Application | Lots | Shares | Amount |
|---|
| Retail (Min — 2 Lots) |
2 |
256 |
₹29,184 |
| Retail (Max — 13 Lots) |
13 |
1,664 |
₹189,696 |
| S-HNI (Min — 14 Lots) |
14 |
1,792 |
₹204,288 |
| S-HNI (Max — 66 Lots) |
66 |
8,448 |
₹963,072 |
| B-HNI (Min — 67 Lots) |
67 |
8,576 |
₹977,664 |
* Issue Price ₹114 × Lot Size 128 shares
Company Financials — Restated Consolidated
(Amount in ₹ Crore)
| Particulars |
30 Jun 2025 |
31 Mar 2025 |
31 Mar 2024 |
| Revenue from Operations |
15.27 |
40.40 |
5.48 |
| EBITDA |
8.63 |
16.55 |
1.95 |
| Profit After Tax (PAT) |
5.40 |
9.50 |
1.71 |
| Net Worth |
30.56 |
25.71 |
10.80 |
| Total Assets |
61.59 |
55.34 |
20.53 |
| Reserves & Surplus |
19.42 |
14.57 |
10.60 |
| Total Borrowings |
4.03 |
3.88 |
1.94 |
| EBITDA Margin (%) |
41.12% |
— | — |
| PAT Margin (%) |
23.61% |
— | — |
Key Ratios & Valuation
Issue Price₹114
Face Value₹2.00 Per Share
Price / Book Value (P/BV)22.62
Return on Equity (RoE)36.61%
Return on Capital Employed (RoCE)37.65%
Return on Net Worth (RoNW)36.61%
PAT Margin (%)23.61%
EBITDA Margin (%)41.12%
Debt / Equity Ratio0.15
Issue Structure & Shareholding
Total Shares Offered2,20,00,000 (100.00%)
Net Offer to PublicNot Available
Reserved for Market MakerNot Available
Pre-Issue Promoter Holding5,68,43,250 shares
Post-Issue Promoter Holding7,88,43,250 shares
Script CodeNot Available
Objects of the Issue
Gujarat Kidney & Super Speciality Ltd. proposes to utilize the net proceeds raised through this IPO for the following objects as stated in the Draft Red Herring Prospectus (DRHP) filed with SEBI:
Issue Composition & Shareholding
Issue TypeBook Built Issue
Sale TypeFresh Capital
Total Shares Offered2,20,00,000 (100.00%)
Net Offer to PublicNot Available
Reserved for Market MakerNot Available
Pre-Issue Promoter Holding5,68,43,250 shares
Post-Issue Promoter Holding7,88,43,250 shares
